Envision Healthcare Corporation (EVHC) Given New $35.00 Price Target at Robert W. Baird

Envision Healthcare Corporation (NYSE:EVHC) had its target price trimmed by Robert W. Baird from $70.00 to $35.00 in a research note released on Friday morning. The brokerage currently has an outperform rating on the stock.

Several other equities research analysts have also recently weighed in on the stock. Mizuho lowered their price target on shares of Envision Healthcare Corporation from $65.00 to $57.00 and set a neutral rating for the company in a research report on Wednesday, August 9th. Zacks Investment Research lowered shares of Envision Healthcare Corporation from a hold rating to a strong sell rating in a research note on Tuesday, October 24th. Citigroup Inc. lowered shares of Envision Healthcare Corporation from a buy rating to a neutral rating and set a $31.00 price objective for the company. in a research note on Thursday. BidaskClub lowered shares of Envision Healthcare Corporation from a sell rating to a strong sell rating in a research note on Thursday, August 17th. Finally, Bank of America Corporation reduced their price objective on shares of Envision Healthcare Corporation from $72.00 to $60.00 and set a buy rating for the company in a research note on Monday, October 9th. Two equities research analysts have rated the stock with a sell rating, five have issued a hold rating, ten have assigned a buy rating and one has given a strong buy rating to the company’s stock. The stock currently has a consensus rating of Buy and an average price target of $49.21.

Envision Healthcare Corporation (NYSE:EVHC) traded down $0.92 during midday trading on Friday, reaching $27.11. 3,585,727 shares of the company’s stock traded hands, compared to its average volume of 5,488,916. The firm has a market cap of $3,292.51, a PE ratio of 8.41 and a beta of 0.69.

Envision Healthcare Corporation (NYSE:EVHC) last announced its earnings results on Tuesday, October 31st. The company reported $0.73 earnings per share for the quarter, missing the Zacks’ consensus estimate of $0.81 by ($0.08). Envision Healthcare Corporation had a negative net margin of 6.39% and a positive return on equity of 4.88%. The business had revenue of $1.99 billion for the quarter, compared to the consensus estimate of $2.03 billion. During the same period in the prior year, the business posted $1.13 EPS. Envision Healthcare Corporation’s revenue for the quarter was up 142.0% on a year-over-year basis. sell-side analysts expect that Envision Healthcare Corporation will post 3.14 EPS for the current year.

COPYRIGHT VIOLATION WARNING: This news story was originally reported by Community Financial News and is owned by of Community Financial News. If you are accessing this news story on another website, it was copied illegally and republished in violation of US and international trademark and copyright legislation. The original version of this news story can be accessed at https://www.com-unik.info/2017/11/03/envision-healthcare-corporation-evhc-given-new-35-00-price-target-at-robert-w-baird.html.

Envision Healthcare Corporation declared that its board has initiated a stock buyback plan on Monday, September 18th that authorizes the company to buyback $250.00 million in outstanding shares. This buyback authorization authorizes the company to purchase up to 4.5% of its shares through open market purchases. Shares buyback plans are usually an indication that the company’s leadership believes its stock is undervalued.

Several hedge funds and other institutional investors have recently modified their holdings of EVHC. Teachers Advisors LLC raised its position in shares of Envision Healthcare Corporation by 1.0% in the first quarter. Teachers Advisors LLC now owns 329,462 shares of the company’s stock valued at $20,203,000 after buying an additional 3,230 shares during the last quarter. Paloma Partners Management Co raised its position in shares of Envision Healthcare Corporation by 37.6% in the first quarter. Paloma Partners Management Co now owns 8,514 shares of the company’s stock valued at $522,000 after buying an additional 2,328 shares during the last quarter. HighTower Advisors LLC raised its position in shares of Envision Healthcare Corporation by 5.6% in the first quarter. HighTower Advisors LLC now owns 4,541 shares of the company’s stock valued at $274,000 after buying an additional 240 shares during the last quarter. Skandinaviska Enskilda Banken AB publ acquired a new stake in shares of Envision Healthcare Corporation in the first quarter valued at about $952,000. Finally, Xact Kapitalforvaltning AB raised its position in shares of Envision Healthcare Corporation by 1.8% in the second quarter. Xact Kapitalforvaltning AB now owns 14,627 shares of the company’s stock valued at $917,000 after buying an additional 258 shares during the last quarter.

Envision Healthcare Corporation Company Profile

Envision Healthcare Holdings, Inc, formerly CDRT Holding Corporation, is a holding company. The Company, through its subsidiary, provides physician-led medical services in the United States. It operates in two segments: EmCare Holdings, Inc (EmCare) and American Medical Response, Inc (AMR). Its EmCare segment is a provider of integrated facility-based and post-acute care physician services to healthcare facilities in the United States.

Analyst Recommendations for Envision Healthcare Corporation (NYSE:EVHC)

What are top analysts saying about Envision Healthcare Corporation? - Enter your email address in the form below to receive our free daily email newsletter that contains the latest headlines and analysts' recommendations for for Envision Healthcare Corporation and related companies.

Comments

Leave a Reply


share news on Facebook
tweet this investment news
share on linkedin
share on StockTwits
share on Google Plus
share on reddit